{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T23:17:00Z","timestamp":1793834220514,"version":"4.6.1"},"reference-count":190,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["K12HD052892"],"award-info":[{"award-number":["K12HD052892"]}],"id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01AI152504"],"award-info":[{"award-number":["R01AI152504"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01HL146542"],"award-info":[{"award-number":["R01HL146542"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01HL132550"],"award-info":[{"award-number":["R01HL132550"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01HL149693"],"award-info":[{"award-number":["R01HL149693"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["K12HD052892"],"award-info":[{"award-number":["K12HD052892"]}],"id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009633","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["K12TR004412"],"award-info":[{"award-number":["K12TR004412"]}],"id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009633","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01AI152504"],"award-info":[{"award-number":["R01AI152504"]}],"id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009633","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01HL146542"],"award-info":[{"award-number":["R01HL146542"]}],"id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009633","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01HL132550"],"award-info":[{"award-number":["R01HL132550"]}],"id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009633","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01HL149693"],"award-info":[{"award-number":["R01HL149693"]}],"id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.atsjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,11,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Although obesity-related asthma is associated with worse asthma outcomes, optimal treatment approaches for this complex phenotype are still largely unavailable. This state-of-the-art review article synthesizes evidence for existing and emerging treatment approaches for obesity-related asthma and highlights pathways that offer potential targets for novel therapeutics. Existing treatments targeting insulin resistance and obesity, including metformin and GLP-1 (glucagon-like-peptide 1) receptor agonists, have been associated with improved asthma outcomes, although GLP-1R agonist data in asthma are limited to individuals with comorbid obesity. Monoclonal antibodies approved for treatment of moderate to severe asthma generally appear to be effective in individuals with obesity, although this is based on retrospective or secondary analysis of clinical trials; moreover, although most of these asthma biologics are approved for use in the pediatric population, the impact of obesity on their efficacy has not been well studied in youth. Potential therapeutic targets being investigated include IL-6, arginine metabolites, nitro-fatty acids, and mitochondrial antioxidants, with clinical trials for each currently underway. Potential therapeutic targets include adipose tissue eosinophils and the GLP-1\u2013arginine\u2013advanced glycation end products axis, although data in humans are still needed. Finally, transcriptomic and epigenetic studies of \u201cobese asthma\u201d demonstrate enrichment of IFN-related signaling pathways, Rho-GTPase pathways, and integrins, suggesting that these too could represent future treatment targets. We advocate for further study of these potential therapeutic mechanisms and continued investigation of the distinct inflammatory pathways characteristic of obesity-related asthma, to facilitate effective treatment development for this unique asthma phenotype.<\/jats:p>","DOI":"10.1164\/rccm.202406-1166so","type":"journal-article","created":{"date-parts":[[2024,9,23]],"date-time":"2024-09-23T11:09:23Z","timestamp":1727089763000},"page":"1186-1200","update-policy":"https:\/\/doi.org\/10.1164\/crossmarkpolicies","source":"Crossref","is-referenced-by-count":56,"title":["Obesity-related Asthma: A Pathobiology-based Overview of Existing and Emerging Treatment Approaches"],"prefix":"10.1093","volume":"210","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3638-7011","authenticated-orcid":false,"given":"Meghan D.","family":"Althoff","sequence":"first","affiliation":[{"name":"Division of Pulmonary Sciences and Critical Care Medicine, Department of Medicine, University of Colorado, Aurora, Colorado"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4618-2984","authenticated-orcid":false,"given":"Kristina","family":"Gaietto","sequence":"additional","affiliation":[{"name":"Division of Pulmonary Medicine, Department of Pediatrics, University of Pittsburgh, Pittsburgh, Pennsylvania; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0979-8234","authenticated-orcid":false,"given":"Fernando","family":"Holguin","sequence":"additional","affiliation":[{"name":"Division of Pulmonary Sciences and Critical Care Medicine, Department of Medicine, University of Colorado, Aurora, Colorado"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6497-9885","authenticated-orcid":false,"given":"Erick","family":"Forno","sequence":"additional","affiliation":[{"name":"Division of Pediatric Pulmonology, Allergy, and Sleep Medicine, Department of Pediatrics, Indiana University, Indianapolis, Indiana"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,11,15]]},"reference":[{"key":"2026022020450290300_bib1","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1111\/all.15807","article-title":"Global, regional, and national burden of allergic disorders and their risk factors in 204 countries and territories, from 1990 to 2019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"78","author":"Shin","year":"2023","journal-title":"Allergy"},{"key":"2026022020450290300_bib2","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/S0140-6736(23)02750-2","article-title":"Worldwide trends in underweight and obesity from 1990 to 2022: a pooled analysis of 3663 population-representative studies with 222 million children, adolescents, and adults","volume":"403","author":"NCD Risk Factor Collaboration (NCD-RisC)","year":"2024","journal-title":"Lancet"},{"key":"2026022020450290300_bib3","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/j.jaci.2018.02.004","article-title":"Obesity and asthma","volume":"141","author":"Peters","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"2026022020450290300_bib4","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/S2352-4642(22)00185-7","article-title":"Obesity-related asthma in children and adolescents","volume":"6","author":"Reyes-Angel","year":"2022","journal-title":"Lancet Child Adolesc Health"},{"key":"2026022020450290300_bib5","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.jaci.2020.08.011","article-title":"Obesity and asthma","volume":"146","author":"Miethe","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"2026022020450290300_bib6","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1055\/s-0042-1742384","article-title":"Obesity and asthma","volume":"43","author":"Dixon","year":"2022","journal-title":"Semin Respir Crit Care Med"},{"key":"2026022020450290300_bib7","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.anai.2023.10.001","article-title":"Management of the pediatric patient with asthma and obesity","volume":"132","author":"Averill","year":"2024","journal-title":"Ann Allergy Asthma Immunol"},{"key":"2026022020450290300_bib8","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1080\/17476348.2020.1706486","article-title":"Contemporary management techniques of asthma in obese patients","volume":"14","author":"Althoff","year":"2020","journal-title":"Expert Rev Respir Med"},{"key":"2026022020450290300_bib9","doi-asserted-by":"crossref","first-page":"3877","DOI":"10.1016\/j.jaip.2021.09.003","article-title":"Asthma and three colinear comorbidities: obesity, OSA, and GERD","volume":"9","author":"Althoff","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"2026022020450290300_bib10","doi-asserted-by":"crossref","first-page":"169","DOI":"10.3390\/jcm10020169","article-title":"Asthma and obesity: two diseases on the rise and bridged by inflammation","volume":"10","author":"Bantul\u00e0","year":"2021","journal-title":"J Clin Med"},{"key":"2026022020450290300_bib11","first-page":"18","article-title":"Oxidative stress and obesity-related asthma","volume":"37","author":"Grasemann","year":"2021","journal-title":"Paediatr Respir Rev"},{"key":"2026022020450290300_bib12","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s40272-022-00554-7","article-title":"Mechanistic links between obesity and airway pathobiology inform therapies for obesity-related asthma","volume":"25","author":"Guerrero","year":"2023","journal-title":"Paediatr Drugs"},{"key":"2026022020450290300_bib13","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.jaip.2023.12.041","article-title":"Weight loss interventions for adults with obesity-related asthma","volume":"12","author":"Foer","year":"2024","journal-title":"J Allergy Clin Immunol Pract"},{"key":"2026022020450290300_bib14","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/j.jaip.2022.02.040","article-title":"An online weight loss intervention for people with obesity and poorly controlled asthma","volume":"10","author":"Johnson","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"key":"2026022020450290300_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1513\/AnnalsATS.201406-271OC","article-title":"Behavioral weight loss and physical activity intervention in obese adults with asthma: a randomized trial","volume":"12","author":"Ma","year":"2015","journal-title":"Ann Am Thorac Soc"},{"key":"2026022020450290300_bib16","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1164\/rccm.201603-0446OC","article-title":"The role of exercise in a weight-loss program on clinical control in obese adults with asthma: a randomized controlled trial","volume":"195","author":"Freitas","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"2026022020450290300_bib17","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1249\/MSS.0000000000001574","article-title":"Exercise improves physical activity and comorbidities in obese adults with asthma","volume":"50","author":"Freitas","year":"2018","journal-title":"Med Sci Sports Exerc"},{"key":"2026022020450290300_bib18","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/cea.12004","article-title":"Dietary restriction and exercise improve airway inflammation and clinical outcomes in overweight and obese asthma: a randomized trial","volume":"43","author":"Scott","year":"2013","journal-title":"Clin Exp Allergy"},{"key":"2026022020450290300_bib19","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1381\/096089299765552981","article-title":"Marked improvement in asthma after Lap-Band surgery for morbid obesity","volume":"9","author":"Dixon","year":"1999","journal-title":"Obes Surg"},{"key":"2026022020450290300_bib20","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.rmed.2007.07.029","article-title":"Weight loss and asthma control in severely obese asthmatic females","volume":"102","author":"Maniscalco","year":"2008","journal-title":"Respir Med"},{"key":"2026022020450290300_bib21","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.rmed.2011.12.012","article-title":"Effect of bariatric surgery on airway response and lung function in obese subjects with asthma","volume":"106","author":"Boulet","year":"2012","journal-title":"Respir Med"},{"key":"2026022020450290300_bib22","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1007\/s00464-018-6500-x","article-title":"Asthma medication usage is significantly reduced following bariatric surgery","volume":"33","author":"Guerron","year":"2019","journal-title":"Surg Endosc"},{"key":"2026022020450290300_bib23","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.jaci.2014.12.1931","article-title":"Risk of an asthma exacerbation after bariatric surgery in adults","volume":"136","author":"Hasegawa","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"2026022020450290300_bib24","doi-asserted-by":"crossref","first-page":"e0214730","DOI":"10.1371\/journal.pone.0214730","article-title":"The impact of bariatric surgery on asthma control differs among obese individuals with reported prior or current asthma, with or without metabolic syndrome","volume":"14","author":"Forno","year":"2019","journal-title":"PLoS One"},{"key":"2026022020450290300_bib25","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.soard.2018.12.018","article-title":"Improvement in pulmonary function in asthmatic patients after bariatric surgery: a systematic review and meta-analysis","volume":"15","author":"Upala","year":"2019","journal-title":"Surg Obes Relat Dis"},{"key":"2026022020450290300_bib26","doi-asserted-by":"crossref","first-page":"4014","DOI":"10.1016\/j.jaip.2021.07.007","article-title":"Metformin use and risk of asthma exacerbation among asthma patients with glycemic dysfunction","volume":"9","author":"Wu","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"2026022020450290300_bib27","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1513\/AnnalsATS.201812-897OC","article-title":"Association of metformin initiation and risk of asthma exacerbation: a claims-based cohort study","volume":"16","author":"Wu","year":"2019","journal-title":"Ann Am Thorac Soc"},{"key":"2026022020450290300_bib28","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/crj.13011","article-title":"The impact of therapy on the risk of asthma in type 2 diabetes","volume":"13","author":"Rayner","year":"2019","journal-title":"Clin Respir J"},{"key":"2026022020450290300_bib29","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1080\/02770903.2017.1283698","article-title":"Insulin use increases risk of asthma but metformin use reduces the risk in patients with diabetes in a Taiwanese population cohort","volume":"54","author":"Chen","year":"2017","journal-title":"J Asthma"},{"key":"2026022020450290300_bib30","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/ppul.26704","article-title":"Metformin use is associated with decreased asthma exacerbations in adolescents and young adults","volume":"59","author":"Ararat","year":"2024","journal-title":"Pediatr Pulmonol"},{"key":"2026022020450290300_bib31","doi-asserted-by":"crossref","first-page":"8211","DOI":"10.3390\/ijerph19138211","article-title":"Metformin and the development of asthma in patients with type 2 diabetes","volume":"19","author":"Yen","year":"2022","journal-title":"Int J Environ Res Public Health"},{"key":"2026022020450290300_bib32","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s00408-023-00611-z","article-title":"The association between insulin use and asthma: an epidemiological observational analysis and Mendelian randomization study","volume":"201","author":"Lin","year":"2023","journal-title":"Lung"},{"key":"2026022020450290300_bib33","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1165\/rcmb.2013-0452OC","article-title":"Hyperinsulinemia potentiates airway responsiveness to parasympathetic nerve stimulation in obese rats","volume":"51","author":"Nie","year":"2014","journal-title":"Am J Respir Cell Mol Biol"},{"key":"2026022020450290300_bib34","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1111\/jcmm.16269","article-title":"Metformin alleviates allergic airway inflammation and increases Treg cells in obese asthma","volume":"25","author":"Guo","year":"2021","journal-title":"J Cell Mol Med"},{"key":"2026022020450290300_bib35","doi-asserted-by":"crossref","first-page":"e76786","DOI":"10.1371\/journal.pone.0076786","article-title":"Metformin attenuates the exacerbation of the allergic eosinophilic inflammation in high fat-diet-induced obesity in mice","volume":"8","author":"Calixto","year":"2013","journal-title":"PLoS One"},{"key":"2026022020450290300_bib36","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1080\/14656566.2023.2192865","article-title":"GLP-1\/GIP analogs: potential impact in the landscape of obesity pharmacotherapy","volume":"24","author":"Lafferty","year":"2023","journal-title":"Expert Opin Pharmacother"},{"key":"2026022020450290300_bib37","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1056\/NEJMoa2032183","article-title":"Once-weekly semaglutide in adults with overweight or obesity","volume":"384","author":"Wilding","year":"2021","journal-title":"N Engl J Med"},{"key":"2026022020450290300_bib38","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1056\/NEJMoa2208601","article-title":"Once-weekly semaglutide in adolescents with obesity","volume":"387","author":"Weghuber","year":"2022","journal-title":"N Engl J Med"},{"key":"2026022020450290300_bib39","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1056\/NEJMoa2206038","article-title":"Tirzepatide once weekly for the treatment of obesity","volume":"387","author":"Jastreboff","year":"2022","journal-title":"N Engl J Med"},{"key":"2026022020450290300_bib40","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/s41574-019-0242-2","article-title":"Understanding the glucoregulatory mechanisms of metformin in type 2 diabetes mellitus","volume":"15","author":"Foretz","year":"2019","journal-title":"Nat Rev Endocrinol"},{"key":"2026022020450290300_bib41","article-title":"Post metabolic bariatric surgery weight regain: the importance of GLP-1 levels","author":"\u00c7al\u0131k Ba\u015faran","journal-title":"Int J Obes (Lond)"},{"key":"2026022020450290300_bib42","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1164\/rccm.202004-0993OC","article-title":"Asthma exacerbations in patients with type 2 diabetes and asthma on glucagon-like peptide-1 receptor agonists","volume":"203","author":"Foer","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"key":"2026022020450290300_bib43","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1164\/rccm.202303-0491OC","article-title":"Association of GLP-1 receptor agonists with chronic obstructive pulmonary disease exacerbations among patients with type 2 diabetes","volume":"208","author":"Foer","year":"2023","journal-title":"Am J Respir Crit Care Med"},{"key":"2026022020450290300_bib44","doi-asserted-by":"crossref","first-page":"e071380","DOI":"10.1136\/bmj-2022-071380","article-title":"Novel antihyperglycaemic drugs and prevention of chronic obstructive pulmonary disease exacerbations among patients with type 2 diabetes: population based cohort study","volume":"379","author":"Pradhan","year":"2022","journal-title":"BMJ"},{"key":"2026022020450290300_bib45","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.2337\/dc20-1794","article-title":"Glucagon-like peptide 1 receptor agonists and chronic lower respiratory disease exacerbations among patients with type 2 diabetes","volume":"44","author":"Albogami","year":"2021","journal-title":"Diabetes Care"},{"key":"2026022020450290300_bib46","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1093\/qjmed\/hcx125","article-title":"Preliminary asthma-related outcomes following glucagon-like peptide 1 agonist therapy","volume":"110","author":"Khan","year":"2017","journal-title":"QJM"},{"key":"2026022020450290300_bib47","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1165\/rcmb.2015-0311OC","article-title":"Glucagon-like peptide 1 receptor: a novel pharmacological target for treating human bronchial hyperresponsiveness","volume":"55","author":"Rogliani","year":"2016","journal-title":"Am J Respir Cell Mol Biol"},{"key":"2026022020450290300_bib48","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/cea.12860","article-title":"Glucagon-like peptide-1 receptor expression on human eosinophils and its regulation of eosinophil activation","volume":"47","author":"Mitchell","year":"2017","journal-title":"Clin Exp Allergy"},{"key":"2026022020450290300_bib49","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.4049\/jimmunol.2300102","article-title":"Glucagon-like peptide-1 receptor pathway attenuates platelet activation in aspirin-exacerbated respiratory disease","volume":"211","author":"Foer","year":"2023","journal-title":"J Immunol"},{"key":"2026022020450290300_bib50","doi-asserted-by":"crossref","first-page":"102003","DOI":"10.1016\/j.pupt.2021.102003","article-title":"Glucagon-like peptide 1 receptor (GLP-1R) agonist relieved asthmatic airway inflammation via suppression of NLRP3 inflammasome activation in obese asthma mice model","volume":"67","author":"Hur","year":"2021","journal-title":"Pulm Pharmacol Ther"},{"key":"2026022020450290300_bib51","doi-asserted-by":"crossref","first-page":"3433","DOI":"10.1111\/all.14879","article-title":"Glucagon-like peptide-1 receptor agonist inhibits aeroallergen-induced activation of ILC2 and neutrophilic airway inflammation in obese mice","volume":"76","author":"Toki","year":"2021","journal-title":"Allergy"},{"key":"2026022020450290300_bib52","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/cea.14252","article-title":"Dual GIPR and GLP-1R agonist tirzepatide inhibits aeroallergen-induced allergic airway inflammation in mouse model of obese asthma","volume":"53","author":"Toki","year":"2023","journal-title":"Clin Exp Allergy"},{"key":"2026022020450290300_bib53","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/cea.14284","article-title":"Glucagon-like peptide-1 receptor agonist use is associated with lower serum periostin","volume":"53","author":"Foer","year":"2023","journal-title":"Clin Exp Allergy"},{"key":"2026022020450290300_bib54","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.jaci.2018.04.037","article-title":"Saturated fatty acids, obesity, and the nucleotide oligomerization domain-like receptor protein 3 (NLRP3) inflammasome in asthmatic patients","volume":"143","author":"Wood","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"2026022020450290300_bib55","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1016\/j.cmet.2024.05.001","article-title":"Glucagon-like peptide 1 receptor is a T cell-negative costimulatory molecule","volume":"36","author":"Ben Nasr","year":"2024","journal-title":"Cell Metab"},{"key":"2026022020450290300_bib56","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1210\/en.2013-1934","article-title":"GLP-1 receptor localization in monkey and human tissue: novel distribution revealed with extensively validated monoclonal antibody","volume":"155","author":"Pyke","year":"2014","journal-title":"Endocrinology"},{"key":"2026022020450290300_bib57","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1038\/s42255-023-00811-0","article-title":"The incretin co-agonist tirzepatide requires GIPR for hormone secretion from human islets","volume":"5","author":"El","year":"2023","journal-title":"Nat Metab"},{"key":"2026022020450290300_bib58","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1056\/NEJMra2032506","article-title":"Biologic therapies for severe asthma","volume":"386","author":"Brusselle","year":"2022","journal-title":"N Engl J Med"},{"key":"2026022020450290300_bib59","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1056\/NEJMoa1009705","article-title":"Randomized trial of omalizumab (anti-IgE) for asthma in inner-city children","volume":"364","author":"Busse","year":"2011","journal-title":"N Engl J Med"},{"key":"2026022020450290300_bib60","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jaip.2013.01.011","article-title":"Reassessment of omalizumab-dosing strategies and pharmacodynamics in inner-city children and adolescents","volume":"1","author":"Sorkness","year":"2013","journal-title":"J Allergy Clin Immunol Pract"},{"key":"2026022020450290300_bib61","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.anai.2022.01.025","article-title":"Impact of body mass index on omalizumab response in adults with moderate-to-severe allergic asthma","volume":"128","author":"Geng","year":"2022","journal-title":"Ann Allergy Asthma Immunol"},{"key":"2026022020450290300_bib62","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.pupt.2014.09.007","article-title":"Asthma control in severe asthmatics under treatment with omalizumab: a cross-sectional observational study in Italy","volume":"31","author":"Novelli","year":"2015","journal-title":"Pulm Pharmacol Ther"},{"key":"2026022020450290300_bib63","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.ejim.2018.01.026","article-title":"Factors reducing omalizumab response in severe asthma","volume":"52","author":"Sposato","year":"2018","journal-title":"Eur J Intern Med"},{"key":"2026022020450290300_bib64","doi-asserted-by":"crossref","first-page":"762318","DOI":"10.3389\/fmed.2021.762318","article-title":"Predictors of a minimal clinically important difference following omalizumab treatment in adult patients with severe allergic asthma","volume":"8","author":"Huang","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"2026022020450290300_bib65","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.pulmoe.2018.01.005","article-title":"Severe asthma in obese patients: improvement of lung function after treatment with omalizumab","volume":"25","author":"Oliveira","year":"2019","journal-title":"Pulmonology"},{"key":"2026022020450290300_bib66","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1111\/cea.13696","article-title":"Obesity influences the outcomes of anti-IgE (omalizumab) therapy of asthma","volume":"50","author":"Gu","year":"2020","journal-title":"Clin Exp Allergy"},{"key":"2026022020450290300_bib67","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1111\/imj.13166","article-title":"Effectiveness and response predictors of omalizumab in a severe allergic asthma population with a high prevalence of comorbidities: the Australian Xolair Registry","volume":"46","author":"Gibson","year":"2016","journal-title":"Intern Med J"},{"key":"2026022020450290300_bib68","doi-asserted-by":"crossref","first-page":"e35247","DOI":"10.1097\/MD.0000000000035247","article-title":"The phenotypic heterogeneity of obese and nonobese patients with severe asthma and comparison of omalizumab-mepolizumab treatment efficiency in these patients","volume":"102","author":"\u00d6zden","year":"2023","journal-title":"Medicine (Baltimore)"},{"key":"2026022020450290300_bib69","doi-asserted-by":"crossref","first-page":"2004605","DOI":"10.1183\/13993003.04605-2020","article-title":"Impact of baseline patient characteristics on dupilumab efficacy in type 2 asthma","volume":"58","author":"Busse","year":"2021","journal-title":"Eur Respir J"},{"key":"2026022020450290300_bib70","doi-asserted-by":"crossref","first-page":"106938","DOI":"10.1016\/j.rmed.2022.106938","article-title":"Dupilumab efficacy in subgroups of type 2 asthma with high-dose inhaled corticosteroids at baseline","volume":"202","author":"Bourdin","year":"2022","journal-title":"Respir Med"},{"key":"2026022020450290300_bib71","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/s12325-018-0702-4","article-title":"Liberty Asthma QUEST: phase 3 randomized, double-blind, placebo-controlled, parallel-group study to evaluate dupilumab efficacy\/safety in patients with uncontrolled, moderate-to-severe asthma","volume":"35","author":"Busse","year":"2018","journal-title":"Adv Ther"},{"key":"2026022020450290300_bib72","doi-asserted-by":"crossref","first-page":"291","DOI":"10.3390\/jcm13010291","article-title":"Clinical remission in patients affected by severe eosinophilic asthma on dupilumab therapy: a long-term real-life study","volume":"13","author":"Quarato","year":"2024","journal-title":"J Clin Med"},{"key":"2026022020450290300_bib73","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1056\/NEJMoa1403290","article-title":"Mepolizumab treatment in patients with severe eosinophilic asthma","volume":"371","author":"Ortega","year":"2014","journal-title":"N Engl J Med"},{"key":"2026022020450290300_bib74","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/S2213-2600(17)30125-X","article-title":"Efficacy of mepolizumab add-on therapy on health-related quality of life and markers of asthma control in severe eosinophilic asthma (MUSCA): a randomised, double-blind, placebo-controlled, parallel-group, multicentre, phase 3b trial","volume":"5","author":"Chupp","year":"2017","journal-title":"Lancet Respir Med"},{"key":"2026022020450290300_bib75","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1186\/s12931-019-1134-7","article-title":"Mepolizumab reduces exacerbations in patients with severe eosinophilic asthma, irrespective of body weight\/body mass index: meta-analysis of MENSA and MUSCA","volume":"20","author":"Albers","year":"2019","journal-title":"Respir Res"},{"key":"2026022020450290300_bib76","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/S0140-6736(12)60988-X","article-title":"Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial","volume":"380","author":"Pavord","year":"2012","journal-title":"Lancet"},{"key":"2026022020450290300_bib77","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1056\/NEJMoa1403291","article-title":"Oral glucocorticoid-sparing effect of mepolizumab in eosinophilic asthma","volume":"371","author":"Bel","year":"2014","journal-title":"N Engl J Med"},{"key":"2026022020450290300_bib78","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1186\/s12931-021-01746-4","article-title":"Mepolizumab improves clinical outcomes in patients with severe asthma and comorbid conditions","volume":"22","author":"Gibson","year":"2021","journal-title":"Respir Res"},{"key":"2026022020450290300_bib79","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.jaip.2022.12.004","article-title":"Comorbidities modify the phenotype but not the treatment effectiveness to mepolizumab in severe eosinophilic asthma","volume":"11","author":"Kritikos","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"key":"2026022020450290300_bib80","doi-asserted-by":"crossref","first-page":"100462","DOI":"10.1016\/j.waojou.2020.100462","article-title":"Real-life effectiveness of mepolizumab in patients with severe refractory eosinophilic asthma and multiple comorbidities","volume":"13","author":"Crimi","year":"2020","journal-title":"World Allergy Organ J"},{"key":"2026022020450290300_bib81","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.anai.2021.05.021","article-title":"Real-world effectiveness of mepolizumab in patients with severe asthma and associated comorbidities","volume":"127","author":"Casale","year":"2021","journal-title":"Ann Allergy Asthma Immunol"},{"key":"2026022020450290300_bib82","doi-asserted-by":"crossref","first-page":"1902420","DOI":"10.1183\/13993003.02420-2019","article-title":"Mepolizumab effectiveness and identification of super-responders in severe asthma","volume":"55","author":"Harvey","year":"2020","journal-title":"Eur Respir J"},{"key":"2026022020450290300_bib83","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1111\/cea.13882","article-title":"Real-world omalizumab and mepolizumab treated difficult asthma phenotypes and their clinical outcomes","volume":"51","author":"Fong","year":"2021","journal-title":"Clin Exp Allergy"},{"key":"2026022020450290300_bib84","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.jaip.2019.09.036","article-title":"Efficacy of intravenous reslizumab in oral corticosteroid-dependent asthma","volume":"8","author":"Nair","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"key":"2026022020450290300_bib85","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1016\/S0140-6736(16)31324-1","article-title":"Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting \u03b2(2)-agonists (SIROCCO): a randomised, multicentre, placebo-controlled phase 3 trial","volume":"388","author":"Bleecker","year":"2016","journal-title":"Lancet"},{"key":"2026022020450290300_bib86","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1016\/S0140-6736(16)31322-8","article-title":"Benralizumab, an anti-interleukin-5 receptor \u03b1 monoclonal antibody, as add-on treatment for patients with severe, uncontrolled, eosinophilic asthma (CALIMA): a randomised, double-blind, placebo-controlled phase 3 trial","volume":"388","author":"FitzGerald","year":"2016","journal-title":"Lancet"},{"key":"2026022020450290300_bib87","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S2213-2600(17)30344-2","article-title":"Predictors of enhanced response with benralizumab for patients with severe asthma: pooled analysis of the SIROCCO and CALIMA studies","volume":"6","author":"FitzGerald","year":"2018","journal-title":"Lancet Respir Med"},{"key":"2026022020450290300_bib88","doi-asserted-by":"crossref","first-page":"00559-2022","DOI":"10.1183\/23120541.00559-2022","article-title":"Clinical response to benralizumab can be predicted by combining clinical outcomes at 3 months with baseline characteristics","volume":"9","author":"Kroes","year":"2023","journal-title":"ERJ Open Res"},{"key":"2026022020450290300_bib89","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1164\/rccm.200711-1754OC","article-title":"Cluster analysis and clinical asthma phenotypes","volume":"178","author":"Haldar","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"2026022020450290300_bib90","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1183\/09031936.00139810","article-title":"Airway inflammation is augmented by obesity and fatty acids in asthma","volume":"38","author":"Scott","year":"2011","journal-title":"Eur Respir J"},{"key":"2026022020450290300_bib91","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1056\/NEJMoa1704064","article-title":"Tezepelumab in adults with uncontrolled asthma","volume":"377","author":"Corren","year":"2017","journal-title":"N Engl J Med"},{"key":"2026022020450290300_bib92","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1186\/s12931-020-01526-6","article-title":"NAVIGATOR: a phase 3 multicentre, randomized, double-blind, placebo-controlled, parallel-group trial to evaluate the efficacy and safety of tezepelumab in adults and adolescents with severe, uncontrolled asthma","volume":"21","author":"Menzies-Gow","year":"2020","journal-title":"Respir Res"},{"key":"2026022020450290300_bib93","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1164\/rccm.202210-2005OC","article-title":"Efficacy of tezepelumab in severe, uncontrolled asthma: pooled analysis of the PATHWAY and NAVIGATOR clinical trials","volume":"208","author":"Corren","year":"2023","journal-title":"Am J Respir Crit Care Med"},{"key":"2026022020450290300_bib94","doi-asserted-by":"crossref","first-page":"2978","DOI":"10.1007\/s12325-024-02889-8","article-title":"Efficacy of tezepelumab in patients with severe, uncontrolled asthma across multiple clinically relevant subgroups in the NAVIGATOR study","volume":"41","author":"Carr","year":"2024","journal-title":"Adv Ther"},{"key":"2026022020450290300_bib95","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.jaip.2019.08.023","article-title":"Underrepresentation of blacks, smokers, and obese patients in studies of monoclonal antibodies for asthma","volume":"8","author":"Akenroye","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"key":"2026022020450290300_bib96","doi-asserted-by":"crossref","first-page":"e2334836","DOI":"10.1001\/jamanetworkopen.2023.34836","article-title":"Surrogate adiposity markers and mortality","volume":"6","author":"Khan","year":"2023","journal-title":"JAMA Netw Open"},{"key":"2026022020450290300_bib97","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/s41586-022-04536-0","article-title":"Obesity alters pathology and treatment response in inflammatory disease","volume":"604","author":"Bapat","year":"2022","journal-title":"Nature"},{"key":"2026022020450290300_bib98","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/s12931-015-0303-6","article-title":"A pilot randomized controlled trial of pioglitazone for the treatment of poorly controlled asthma in obesity","volume":"16","author":"Dixon","year":"2015","journal-title":"Respir Res"},{"key":"2026022020450290300_bib99","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1016\/j.jaci.2017.05.033","article-title":"A randomized, placebo-controlled, double-blinded, crossover trial of pioglitazone for severe asthma","volume":"140","author":"Kaler","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"2026022020450290300_bib100","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1172\/JCI57132","article-title":"Inflammatory links between obesity and metabolic disease","volume":"121","author":"Lumeng","year":"2011","journal-title":"J Clin Invest"},{"key":"2026022020450290300_bib101","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/S2213-2600(16)30048-0","article-title":"Plasma interleukin-6 concentrations, metabolic dysfunction, and asthma severity: a cross-sectional analysis of two cohorts","volume":"4","author":"Peters","year":"2016","journal-title":"Lancet Respir Med"},{"key":"2026022020450290300_bib102","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1016\/j.jaci.2020.01.021","article-title":"Serum IL-6: a biomarker in childhood asthma?","volume":"145","author":"Jackson","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"2026022020450290300_bib103","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1183\/13993003.02198-2015","article-title":"Comorbidities and elevated IL-6 associate with negative outcome in adult-onset asthma","volume":"48","author":"Ilmarinen","year":"2016","journal-title":"Eur Respir J"},{"key":"2026022020450290300_bib104","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.jaci.2019.04.007","article-title":"Evidence for an IL-6-high asthma phenotype in asthmatic patients of African ancestry","volume":"144","author":"White","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"2026022020450290300_bib105","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1186\/s12931-023-02617-w","article-title":"An epithelial gene signature of trans-IL-6 signaling defines a subgroup of type 2-low asthma","volume":"24","author":"El-Husseini","year":"2023","journal-title":"Respir Res"},{"key":"2026022020450290300_bib106","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.jaci.2018.05.026","article-title":"Epithelial IL-6 trans-signaling defines a new asthma phenotype with increased airway inflammation","volume":"143","author":"Jevnikar","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"2026022020450290300_bib107","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1164\/rccm.201909-1813OC","article-title":"Evidence for exacerbation-prone asthma and predictive biomarkers of exacerbation frequency","volume":"202","author":"Peters","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"2026022020450290300_bib108","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1016\/j.jaip.2019.02.043","article-title":"Treatment of severe persistent asthma with IL-6 receptor blockade","volume":"7","author":"Esty","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"2026022020450290300_bib109","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.jaci.2021.10.035","article-title":"The Precision Interventions for Severe and\/or Exacerbation-Prone (PrecISE) Asthma Network: an overview of Network organization, procedures, and interventions","volume":"149","author":"Georas","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"2026022020450290300_bib110","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.iac.2014.07.007","article-title":"Arginine metabolism in asthma","volume":"34","author":"Scott","year":"2014","journal-title":"Immunol Allergy Clin North Am"},{"key":"2026022020450290300_bib111","doi-asserted-by":"crossref","first-page":"627503","DOI":"10.3389\/fphar.2021.627503","article-title":"Arginine therapy for lung diseases","volume":"12","author":"Scott","year":"2021","journal-title":"Front Pharmacol"},{"key":"2026022020450290300_bib112","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1183\/09031936.00080313","article-title":"Asymmetric dimethylarginine and asthma","volume":"43","author":"Scott","year":"2014","journal-title":"Eur Respir J"},{"key":"2026022020450290300_bib113","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1465-9921-8-32","article-title":"Body mass index is associated with reduced exhaled nitric oxide and higher exhaled 8-isoprostanes in asthmatics","volume":"8","author":"Komakula","year":"2007","journal-title":"Respir Res"},{"key":"2026022020450290300_bib114","doi-asserted-by":"crossref","first-page":"e001683","DOI":"10.1136\/bmjresp-2023-001683","article-title":"Phenotypic characteristics of asthma and morbidity are associated with distinct longitudinal changes in L-arginine metabolism","volume":"10","author":"Althoff","year":"2023","journal-title":"BMJ Open Respir Res"},{"key":"2026022020450290300_bib115","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1164\/rccm.201207-1270OC","article-title":"An association between L-arginine\/asymmetric dimethyl arginine balance, obesity, and the age of asthma onset phenotype","volume":"187","author":"Holguin","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"2026022020450290300_bib116","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1089\/ars.2018.7627","article-title":"Bioenergetic differences in the airway epithelium of lean versus obese asthmatics are driven by nitric oxide and reflected in circulating platelets","volume":"31","author":"Winnica","year":"2019","journal-title":"Antioxid Redox Signal"},{"key":"2026022020450290300_bib117","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1038\/s41598-018-20549-0","article-title":"Asymmetric dimethylarginine (ADMA) is identified as a potential biomarker of insulin resistance in skeletal muscle","volume":"8","author":"Lee","year":"2018","journal-title":"Sci Rep"},{"key":"2026022020450290300_bib118","doi-asserted-by":"crossref","first-page":"e0129850","DOI":"10.1371\/journal.pone.0129850","article-title":"Metabolic syndrome is associated with increased oxo-nitrative stress and asthma-like changes in lungs","volume":"10","author":"Singh","year":"2015","journal-title":"PLoS One"},{"key":"2026022020450290300_bib119","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1164\/rccm.200710-1588OC","article-title":"Arginase inhibition protects against allergen-induced airway obstruction, hyperresponsiveness, and inflammation","volume":"178","author":"Maarsingh","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"2026022020450290300_bib120","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1183\/09031936.00105408","article-title":"L-arginine deficiency causes airway hyperresponsiveness after the late asthmatic reaction","volume":"34","author":"Maarsingh","year":"2009","journal-title":"Eur Respir J"},{"key":"2026022020450290300_bib121","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.jaci.2009.10.065","article-title":"Beneficial effects of high dose of L-arginine on airway hyperresponsiveness and airway inflammation in a murine model of asthma","volume":"125","author":"Mabalirajan","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"2026022020450290300_bib122","doi-asserted-by":"crossref","first-page":"e137777","DOI":"10.1172\/jci.insight.137777","article-title":"l-arginine supplementation in severe asthma","volume":"5","author":"Liao","year":"2020","journal-title":"JCI Insight"},{"key":"2026022020450290300_bib123","doi-asserted-by":"crossref","first-page":"187","DOI":"10.3390\/ph4010187","article-title":"l-arginine supplementation and metabolism in asthma","volume":"4","author":"Kenyon","year":"2011","journal-title":"Pharmaceuticals (Basel)"},{"key":"2026022020450290300_bib124","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/j.1365-2125.2007.02990.x","article-title":"Pharmacokinetic and pharmacodynamic properties of oral L-citrulline and L-arginine: impact on nitric oxide metabolism","volume":"65","author":"Schwedhelm","year":"2008","journal-title":"Br J Clin Pharmacol"},{"key":"2026022020450290300_bib125","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/cea.12802","article-title":"l-citrulline prevents asymmetric dimethylarginine-mediated reductions in nitric oxide and nitrosative stress in primary human airway epithelial cells","volume":"47","author":"Winnica","year":"2017","journal-title":"Clin Exp Allergy"},{"key":"2026022020450290300_bib126","doi-asserted-by":"crossref","first-page":"4116","DOI":"10.3390\/nu13114116","article-title":"Dysregulated arginine metabolism in young patients with chronic persistent asthma and in human bronchial epithelial cells","volume":"13","author":"Zhou","year":"2021","journal-title":"Nutrients"},{"key":"2026022020450290300_bib127","doi-asserted-by":"crossref","first-page":"e131733","DOI":"10.1172\/jci.insight.131733","article-title":"L-citrulline increases nitric oxide and improves control in obese asthmatics","volume":"4","author":"Holguin","year":"2019","journal-title":"JCI Insight"},{"key":"2026022020450290300_bib128","doi-asserted-by":"crossref","first-page":"e2208924120","DOI":"10.1073\/pnas.2208924120","article-title":"Nitro-oleic acid regulates T cell activation through post-translational modification of calcineurin","volume":"120","author":"Bago","year":"2023","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026022020450290300_bib129","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.niox.2018.07.003","article-title":"Nitro-fatty acid formation and metabolism","volume":"79","author":"Buchan","year":"2018","journal-title":"Nitric Oxide"},{"key":"2026022020450290300_bib130","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1146\/annurev-physiol-021113-170341","article-title":"Redox-dependent anti-inflammatory signaling actions of unsaturated fatty acids","volume":"76","author":"Delmastro-Greenwood","year":"2014","journal-title":"Annu Rev Physiol"},{"key":"2026022020450290300_bib131","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1093\/cvr\/cvt341","article-title":"Fatty acid nitroalkenes ameliorate glucose intolerance and pulmonary hypertension in high-fat diet-induced obesity","volume":"101","author":"Kelley","year":"2014","journal-title":"Cardiovasc Res"},{"key":"2026022020450290300_bib132","doi-asserted-by":"crossref","first-page":"101132","DOI":"10.1016\/j.redox.2019.101132","article-title":"Electrophilic nitro-oleic acid reverses obesity-induced hepatic steatosis","volume":"22","author":"Khoo","year":"2019","journal-title":"Redox Biol"},{"key":"2026022020450290300_bib133","doi-asserted-by":"crossref","first-page":"9052","DOI":"10.3390\/ijms22169052","article-title":"Nitro-oleic acid (NO(2)-OA) improves systolic function in dilated cardiomyopathy by attenuating myocardial fibrosis","volume":"22","author":"Braumann","year":"2021","journal-title":"Int J Mol Sci"},{"key":"2026022020450290300_bib134","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.niox.2018.06.006","article-title":"Nitro-fatty acids: new drug candidates for chronic inflammatory and fibrotic diseases","volume":"79","author":"Schopfer","year":"2018","journal-title":"Nitric Oxide"},{"key":"2026022020450290300_bib135","doi-asserted-by":"crossref","first-page":"17788","DOI":"10.1038\/s41598-021-96471-9","article-title":"Nitroalkene fatty acids modulate bile acid metabolism and lung function in obese asthma","volume":"11","author":"Manni","year":"2021","journal-title":"Sci Rep"},{"key":"2026022020450290300_bib136","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.jaci.2019.10.014","article-title":"Untargeted metabolomic profiling identifies disease-specific signatures in food allergy and asthma","volume":"145","author":"Crestani","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"2026022020450290300_bib137","doi-asserted-by":"crossref","first-page":"643","DOI":"10.4049\/jimmunol.1500736","article-title":"Metabolomic endotype of asthma","volume":"195","author":"Comhair","year":"2015","journal-title":"J Immunol"},{"key":"2026022020450290300_bib138","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1053\/j.gastro.2017.01.055","article-title":"Bile acid control of metabolism and inflammation in obesity, type 2 diabetes, dyslipidemia, and nonalcoholic fatty liver disease","volume":"152","author":"Ch\u00e1vez-Talavera","year":"2017","journal-title":"Gastroenterology"},{"key":"2026022020450290300_bib139","doi-asserted-by":"crossref","DOI":"10.3389\/frmbi.2023.1153691","article-title":"Meta-omics profiling of the gut-lung axis illuminates metabolic networks and host-microbial interactions associated with elevated lung elastance in a murine model of obese allergic asthma","volume":"2","author":"Heinrich","year":"2023","journal-title":"Front Microbiomes"},{"key":"2026022020450290300_bib140","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.4049\/jimmunol.1300730","article-title":"The nitrated fatty acid 10-nitro-oleate attenuates allergic airway disease","volume":"191","author":"Reddy","year":"2013","journal-title":"J Immunol"},{"key":"2026022020450290300_bib141","doi-asserted-by":"crossref","first-page":"S368","DOI":"10.1513\/AnnalsATS.201701-042AW","article-title":"Mitochondrial dysfunction linking obesity and asthma","volume":"14","author":"Bhatraju","year":"2017","journal-title":"Ann Am Thorac Soc"},{"key":"2026022020450290300_bib142","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.3892\/mmr.2015.4663","article-title":"Correlation between oxidative stress and the NF-\u03baB signaling pathway in the pulmonary tissues of obese asthmatic mice","volume":"13","author":"Liu","year":"2016","journal-title":"Mol Med Rep"},{"key":"2026022020450290300_bib143","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.alit.2017.06.002","article-title":"Obesity-related systemic oxidative stress: an important factor of poor asthma control","volume":"67","author":"To","year":"2018","journal-title":"Allergol Int"},{"key":"2026022020450290300_bib144","first-page":"577","article-title":"Moderate endurance training and MitoQ improve cardiovascular function, oxidative stress, and inflammation in hypertensive individuals: the role of miR-21 and miR-222: a randomized, double-blind, clinical trial","volume":"24","author":"Masoumi-Ardakani","year":"2022","journal-title":"Cell J"},{"key":"2026022020450290300_bib145","doi-asserted-by":"crossref","first-page":"114680","DOI":"10.1016\/j.biopha.2023.114680","article-title":"Mitoquinone ameliorated airway inflammation by stabilizing \u03b2-catenin destruction complex in a steroid-insensitive asthma model","volume":"162","author":"Huang","year":"2023","journal-title":"Biomed Pharmacother"},{"key":"2026022020450290300_bib146","doi-asserted-by":"crossref","first-page":"L141","DOI":"10.1152\/ajplung.00249.2022","article-title":"Mitoquinone mesylate attenuates pathological features of lean and obese allergic asthma in mice","volume":"324","author":"Chandrasekaran","year":"2023","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"2026022020450290300_bib147","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.3390\/antiox10071029","article-title":"Maternal particulate matter exposure impairs lung health and is associated with mitochondrial damage","volume":"10","author":"Wang","year":"2021","journal-title":"Antioxidants (Basel)"},{"key":"2026022020450290300_bib148","doi-asserted-by":"crossref","first-page":"466","DOI":"10.3892\/etm.2021.9897","article-title":"Regulatory effect of mitoQ on the mtROS-NLRP3 inflammasome pathway in leptin-pretreated BEAS-2 cells","volume":"21","author":"Chong","year":"2021","journal-title":"Exp Ther Med"},{"key":"2026022020450290300_bib149","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/JLB.5MR0120-377R","article-title":"Unraveling the connection between eosinophils and obesity","volume":"108","author":"Calco","year":"2020","journal-title":"J Leukoc Biol"},{"key":"2026022020450290300_bib150","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1093\/jleuko\/qiac009","article-title":"Blood and adipose-resident eosinophils are defined by distinct transcriptional profiles","volume":"113","author":"Shah","year":"2023","journal-title":"J Leukoc Biol"},{"key":"2026022020450290300_bib151","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1111\/1440-1681.13304","article-title":"EoTHINophils: eosinophils as key players in adipose tissue homeostasis","volume":"47","author":"Vohralik","year":"2020","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"2026022020450290300_bib152","doi-asserted-by":"crossref","first-page":"9894","DOI":"10.1038\/s41598-018-28371-4","article-title":"Eosinophils support adipocyte maturation and promote glucose tolerance in obesity","volume":"8","author":"Lee","year":"2018","journal-title":"Sci Rep"},{"key":"2026022020450290300_bib153","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/nature14115","article-title":"Group 2 innate lymphoid cells promote beiging of white adipose tissue and limit obesity","volume":"519","author":"Brestoff","year":"2015","journal-title":"Nature"},{"key":"2026022020450290300_bib154","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1016\/j.cell.2014.03.066","article-title":"Eosinophils and type 2 cytokine signaling in macrophages orchestrate development of functional beige fat","volume":"157","author":"Qiu","year":"2014","journal-title":"Cell"},{"key":"2026022020450290300_bib155","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/s42255-020-0228-3","article-title":"Eosinophils regulate adipose tissue inflammation and sustain physical and immunological fitness in old age","volume":"2","author":"Brigger","year":"2020","journal-title":"Nat Metab"},{"key":"2026022020450290300_bib156","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1126\/science.1201475","article-title":"Eosinophils sustain adipose alternatively activated macrophages associated with glucose homeostasis","volume":"332","author":"Wu","year":"2011","journal-title":"Science"},{"key":"2026022020450290300_bib157","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.bbadis.2013.05.017","article-title":"Cellular and molecular players in adipose tissue inflammation in the development of obesity-induced insulin resistance","volume":"1842","author":"Lee","year":"2014","journal-title":"Biochim Biophys Acta"},{"key":"2026022020450290300_bib158","doi-asserted-by":"crossref","first-page":"3027","DOI":"10.1096\/fj.14-266239","article-title":"Chronic helminth infection and helminth-derived egg antigens promote adipose tissue M2 macrophages and improve insulin sensitivity in obese mice","volume":"29","author":"Hussaarts","year":"2015","journal-title":"FASEB J"},{"key":"2026022020450290300_bib159","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.molmet.2017.12.004","article-title":"Elevating adipose eosinophils in obese mice to physiologically normal levels does not rescue metabolic impairments","volume":"8","author":"Bolus","year":"2018","journal-title":"Mol Metab"},{"key":"2026022020450290300_bib160","doi-asserted-by":"crossref","first-page":"1901874","DOI":"10.1183\/13993003.01874-2019","article-title":"Blood eosinophil count in the general population: typical values and potential confounders","volume":"55","author":"Hartl","year":"2020","journal-title":"Eur Respir J"},{"key":"2026022020450290300_bib161","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.alit.2019.05.012","article-title":"Correlation between eosinophil count, its genetic background and body mass index: the Nagahama Study","volume":"69","author":"Sunadome","year":"2020","journal-title":"Allergol Int"},{"key":"2026022020450290300_bib162","doi-asserted-by":"crossref","first-page":"2748","DOI":"10.1016\/j.jaip.2023.06.054","article-title":"Long-term weight changes after starting anti-IL-5\/5Ra biologics in severe asthma: the role of oral corticosteroids","volume":"11","author":"Ten Have","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"key":"2026022020450290300_bib163","doi-asserted-by":"crossref","first-page":"2300245","DOI":"10.1183\/13993003.00245-2023","article-title":"The impact of steroid-sparing biologic therapies on weight loss in obese individuals with severe eosinophilic asthma","volume":"62","author":"Nanzer","year":"2023","journal-title":"Eur Respir J"},{"key":"2026022020450290300_bib164","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.anai.2019.03.031","article-title":"Association of antieosinophil therapy with decreased body mass index in patients with severe asthma: a preliminary retrospective analysis","volume":"122","author":"Kuruvilla","year":"2019","journal-title":"Ann Allergy Asthma Immunol"},{"key":"2026022020450290300_bib165","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jdiacomp.2019.05.010","article-title":"Increased eosinophils in adipose tissue of metabolic syndrome","volume":"33","author":"Moussa","year":"2019","journal-title":"J Diabetes Complications"},{"key":"2026022020450290300_bib166","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.1161\/ATVBAHA.114.304636","article-title":"T-cell profile in adipose tissue is associated with insulin resistance and systemic inflammation in humans","volume":"34","author":"McLaughlin","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2026022020450290300_bib167","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1038\/nm.2001","article-title":"Normalization of obesity-associated insulin resistance through immunotherapy","volume":"15","author":"Winer","year":"2009","journal-title":"Nat Med"},{"key":"2026022020450290300_bib168","doi-asserted-by":"crossref","first-page":"eabj6879","DOI":"10.1126\/scitranslmed.abj6879","article-title":"Innate PD-L1 limits T cell-mediated adipose tissue inflammation and ameliorates diet-induced obesity","volume":"14","author":"Schwartz","year":"2022","journal-title":"Sci Transl Med"},{"key":"2026022020450290300_bib169","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S2213-2600(17)30051-6","article-title":"Obesity-related, metabolic asthma: a new role for glucagon-like peptide 1 agonists","volume":"5","author":"Nguyen","year":"2017","journal-title":"Lancet Respir Med"},{"key":"2026022020450290300_bib170","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.rmed.2010.10.016","article-title":"Increased levels of HMGB-1 and endogenous secretory RAGE in induced sputum from asthmatic patients","volume":"105","author":"Watanabe","year":"2011","journal-title":"Respir Med"},{"key":"2026022020450290300_bib171","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1111\/bph.13539","article-title":"The receptor for advanced glycation end products is required for \u03b2-catenin stabilization in a chemical-induced asthma model","volume":"173","author":"Yao","year":"2016","journal-title":"Br J Pharmacol"},{"key":"2026022020450290300_bib172","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/j.ajpath.2012.06.031","article-title":"The receptor for advanced glycation end products is a central mediator of asthma pathogenesis","volume":"181","author":"Milutinovic","year":"2012","journal-title":"Am J Pathol"},{"key":"2026022020450290300_bib173","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.pharmthera.2017.06.012","article-title":"Glucagon-like peptide 1: a potential anti-inflammatory pathway in obesity-related asthma","volume":"180","author":"Nguyen","year":"2017","journal-title":"Pharmacol Ther"},{"key":"2026022020450290300_bib174","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1080\/13813455.2017.1348362","article-title":"Exendin-4, a glucagon-like peptide-1 receptor agonist downregulates hepatic receptor for advanced glycation end products in non-alcoholic steatohepatitis rat model","volume":"124","author":"Allam","year":"2018","journal-title":"Arch Physiol Biochem"},{"key":"2026022020450290300_bib175","doi-asserted-by":"crossref","first-page":"3978","DOI":"10.1210\/en.2013-1529","article-title":"Oral L-arginine stimulates GLP-1 secretion to improve glucose tolerance in male mice","volume":"154","author":"Clemmensen","year":"2013","journal-title":"Endocrinology"},{"key":"2026022020450290300_bib176","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1002\/osp4.500","article-title":"L-arginine as a potential GLP-1-mediated immunomodulator of Th17-related cytokines in people with obesity and asthma","volume":"7","author":"Liao","year":"2021","journal-title":"Obes Sci Pract"},{"key":"2026022020450290300_bib177","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ajpath.2012.09.016","article-title":"Glucagon-like peptide-1 receptor agonist inhibits asymmetric dimethylarginine generation in the kidney of streptozotocin-induced diabetic rats by blocking advanced glycation end product-induced protein arginine methyltranferase-1 expression","volume":"182","author":"Ojima","year":"2013","journal-title":"Am J Pathol"},{"key":"2026022020450290300_bib178","doi-asserted-by":"crossref","first-page":"4398","DOI":"10.3390\/jcm12134398","article-title":"Effect of obesity on the expression of genes associated with severe asthma: a pilot study","volume":"12","author":"Bantul\u00e0","year":"2023","journal-title":"J Clin Med"},{"key":"2026022020450290300_bib179","doi-asserted-by":"crossref","first-page":"10144","DOI":"10.3390\/ijms221810144","article-title":"Differential regulation of interferon signaling pathways in CD4(+) T cells of the low type-2 obesity-associated asthma phenotype","volume":"22","author":"Alhamdan","year":"2021","journal-title":"Int J Mol Sci"},{"key":"2026022020450290300_bib180","doi-asserted-by":"crossref","first-page":"2944","DOI":"10.1111\/all.15824","article-title":"Identification of extracellular vesicle microRNA signatures specifically linked to inflammatory and metabolic mechanisms in obesity-associated low type-2 asthma","volume":"78","author":"Alhamdan","year":"2023","journal-title":"Allergy"},{"key":"2026022020450290300_bib181","doi-asserted-by":"crossref","first-page":"e13776","DOI":"10.1111\/pai.13776","article-title":"Differential gene expression in nasal airway epithelium from overweight or obese youth with asthma","volume":"33","author":"Xu","year":"2022","journal-title":"Pediatr Allergy Immunol"},{"key":"2026022020450290300_bib182","first-page":"A7163","article-title":"Adipose tissue transcriptomics and measures of obesity-related asthma in children [abstract]","volume":"209","author":"Gaietto","year":"2024","journal-title":"Am J Respir Crit Care Med"},{"key":"2026022020450290300_bib183","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1164\/rccm.201906-1199OC","article-title":"Functional genomics of the pediatric obese asthma phenotype reveal enrichment of Rho-GTPase pathways","volume":"202","author":"Rastogi","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"2026022020450290300_bib184","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.jaci.2017.04.016","article-title":"CDC42-related genes are upregulated in helper T cells from obese asthmatic children","volume":"141","author":"Rastogi","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"2026022020450290300_bib185","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.jaci.2022.04.033","article-title":"Endotyping pediatric obesity-related asthma: contribution of anthropometrics, metabolism, nutrients, and CD4(+) lymphocytes to pulmonary function","volume":"150","author":"Thompson","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"2026022020450290300_bib186","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3389\/fimmu.2016.00006","article-title":"TCR signal strength alters T-DC activation and interaction times and directs the outcome of differentiation","volume":"7","author":"van Panhuys","year":"2016","journal-title":"Front Immunol"},{"key":"2026022020450290300_bib187","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.4049\/jimmunol.1200156","article-title":"Cytokine secretion by CD4+ T cells at the immunological synapse requires Cdc42-dependent local actin remodeling but not microtubule organizing center polarity","volume":"189","author":"Chemin","year":"2012","journal-title":"J Immunol"},{"key":"2026022020450290300_bib188","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1164\/rccm.202205-0985OC","article-title":"Crosstalk between CD4(+) T cells and airway smooth muscle in pediatric obesity-related asthma","volume":"207","author":"Yon","year":"2023","journal-title":"Am J Respir Crit Care Med"},{"key":"2026022020450290300_bib189","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1002\/oby.22341","article-title":"Gene coexpression networks in whole blood implicate multiple interrelated molecular pathways in obesity in people with asthma","volume":"26","author":"Croteau-Chonka","year":"2018","journal-title":"Obesity (Silver Spring)"},{"key":"2026022020450290300_bib190","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.tips.2014.09.006","article-title":"Integrins: therapeutic targets in airway hyperresponsiveness and remodelling?","volume":"35","author":"Wright","year":"2014","journal-title":"Trends Pharmacol Sci"}],"container-title":["American Journal of Respiratory and Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajrccm\/article-pdf\/210\/10\/1186\/66997727\/ajrccm_210_10_1186.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajrccm\/article-pdf\/210\/10\/1186\/66997727\/ajrccm_210_10_1186.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T01:45:38Z","timestamp":1771638338000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajrccm\/article\/210\/10\/1186\/8491422"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":190,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2024,11,15]]},"published-print":{"date-parts":[[2024,11,15]]}},"URL":"https:\/\/doi.org\/10.1164\/rccm.202406-1166so","relation":{},"ISSN":["1073-449X","1535-4970"],"issn-type":[{"value":"1073-449X","type":"print"},{"value":"1535-4970","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,11]]},"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"2024-06-13","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-09-20","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-11-15","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}